Physician

Joshua Holstead, MD

According to 2025 Medicare claims, Joshua Holstead, MD (NPI: 1629396460) practices urology in the Alexandria, LA market, with the plurality of this provider's patient population coming from Rapides, LA. This provider's primary affiliated billing organization is CENLA UROLOGY CLINIC LLC (NPI: 1487879094; TIN: 720597185) and primary practice location at 71301-3917.

Holstead's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 657 traditional Medicare patients, billed 31,812 HCPCS/CPT codes, and received $302,151 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,444 prescription claims across 590 beneficiaries totaling $362,472 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 68 claims. Open Payments data shows 47 records totaling $968. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $40,204 to $302,151. Similarly, Part D prescription costs have risen steadily, from $15,576 to $362,472. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $956 to $364.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$476K$953K2015 Medicare payment: $40,204 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $182,779 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $139,839 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $193,085 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $315,591 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $424,607 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $616,043 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $952,958 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $461,244 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $302,151 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015161427$40,204
20164791,673$182,779
20174843,580$139,839
201854512,844$193,085
201974825,068$315,591
20201,18549,925$424,607
20211,17460,017$616,043
20221,13474,583$952,958
202399933,497$461,244
202465731,812$302,151

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$195K$391K2015 Drug cost: $15,576 (USD; Tot_Drug_Cst)2016 Drug cost: $65,544 (USD; Tot_Drug_Cst)2017 Drug cost: $74,154 (USD; Tot_Drug_Cst)2018 Drug cost: $84,499 (USD; Tot_Drug_Cst)2019 Drug cost: $225,169 (USD; Tot_Drug_Cst)2020 Drug cost: $302,331 (USD; Tot_Drug_Cst)2021 Drug cost: $390,556 (USD; Tot_Drug_Cst)2022 Drug cost: $288,766 (USD; Tot_Drug_Cst)2023 Drug cost: $314,512 (USD; Tot_Drug_Cst)2024 Drug cost: $362,472 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201583206$15,576
2016231907$65,544
2017259916$74,154
2018262902$84,499
20194321,559$225,169
20205302,028$302,331
20215712,136$390,556
20226342,462$288,766
20235682,192$314,512
20245902,444$362,472

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$22K$43K2016 Medicare payment: $29,560 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $43,466 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $20,758 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $8,044 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $21,901 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $16,507 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $12,142 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $12,062 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $19,621 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
201616121$29,560
2017N/R95$43,466
2018N/R42$20,758
2019N/R31$8,044
2020N/R83$21,901
2021N/R79$16,507
2022N/R64$12,142
2023N/R47$12,062
2024N/R68$19,621

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more226282$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more182233$63
36415Insertion of needle into vein for collection of blood sample8082$9
51798Ultrasound measurement of bladder capacity after voiding79100$8
81003Automated urinalysis test365553$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MyrbetriqMirabegron1636,935$102,895
GemtesaVibegron1576,400$100,247
NitrofurantoinNitrofurantoin Macrocrystal22711,870$7,935
Solifenacin SuccinateSolifenacin Succinate23111,810$5,280
Tamsulosin HclTamsulosin Hcl38426,739$4,727

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R50$19,257
A4332Lubricant, individual sterile packet, eachNN/R18$364

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.47$968Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joshua Holstead, MD?

Tedicare shows public-source Medicare data for Joshua Holstead, MD (NPI 1629396460), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joshua Holstead, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joshua Holstead, MD?

Joshua Holstead, MD is linked to CENLA UROLOGY CLINIC LLC (billing NPI 1487879094) in the available physician profile data.

Does Joshua Holstead, MD have Open Payments data?

Joshua Holstead, MD has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.